GlassScriptPhysician profile
Steven Paul Bondi
NPI 1205282217
$12,945.67
in general payments reported to CMS, 2019-2025
60 companies · $3,589 in 2025
The $3,589 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $546 · 2022: $2,513 · 2023: $3,101 · 2024: $3,196 · 2025: $3,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,857 · Education: $29.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,857.30 |
| Education | $29.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,212.14 | 2021-2025 | Qulipta, Ubrelvy, Duopa |
| Novartis Pharmaceuticals Corporation | $919.55 | 2022-2025 | |
| Pfizer INC. | $885.06 | 2022-2025 | |
| Celgene Corporation | $675.46 | 2022-2024 | Zeposia |
| Emd Serono, INC. | $659.97 | 2021-2025 | Mavenclad |
| Ucb, INC. | $581.66 | 2023-2025 | Rystiggo, Nayzilam, Briviact |
| Genentech USA, INC. | $537.01 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Tg Therapeutics, INC. | $440.86 | 2023-2025 | |
| Mdd US Operations, LLC | $426.48 | 2022-2025 | Gocovri, Gocovri |
| Acadia Pharmaceuticals INC | $394.43 | 2022-2025 | Nuplazid |
| Lundbeck LLC | $381.11 | 2021-2025 | Vyepti |
| Amneal Pharmaceuticals LLC | $378.46 | 2021-2024 | Rytary |
| Biogen, INC. | $358.68 | 2022-2024 | Vumerity, Tysabri |
| Kyowa Kirin, INC. | $343.62 | 2021-2024 | Nourianz |
| Sk Life Science, INC. | $338.34 | 2021-2024 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $295.90 | 2022-2025 | Ultomiris, Soliris |
| Argenx US, INC. | $268.92 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Teva Pharmaceuticals USA, INC. | $216.16 | 2021-2025 | Austedo Xr, Austedo Xr |
| Genzyme Corporation | $189.13 | 2021-2025 | |
| Amgen INC. | $184.75 | 2024-2025 | Uplizna, Repatha |
| Neurocrine Biosciences, INC. | $179.83 | 2022-2024 | Ingrezza |
| Biohaven Pharmaceutical Holding Company LTD. | $178.24 | 2022 | |
| Eisai INC. | $173.46 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $165.53 | 2021-2023 | Ponvory |
| Vanda Pharmaceuticals INC. | $142.62 | 2024-2025 | Ponvory |
| Axsome Therapeutics, INC. | $141.32 | 2025 | Symbravo |
| Catalyst Pharmaceuticals, INC. | $134.86 | 2021-2025 | Firdapse |
| Lilly USA, LLC | $134.82 | 2022-2025 | Kisunla, Emgality, Amyvid |
| Octapharma USA, INC. | $123.04 | 2024-2025 | Panzyga |
| Impel Pharmaceuticals INC. | $118.52 | 2022-2023 | Trudhesa |
| Takeda Pharmaceuticals U.S.A., INC. | $111.76 | 2023-2025 | Hyqvia |
| Alnylam Pharmaceuticals INC. | $102.41 | 2022-2024 | Onpattro |
| Grifols USA, LLC | $97.66 | 2023-2025 | Gamunex-C |
| Horizon Therapeutics Plc | $94.21 | 2022-2023 | Uplizna |
| Azurity Pharmaceuticals, INC. | $91.21 | 2023 | Horizant |
| Upsher-Smith Laboratories LLC | $87.13 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $82.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $82.13 | 2024-2025 | Wainua, Andexxa |
| Tanabe Pharma America, INC. | $81.63 | 2023-2025 | Radicava |
| Almatica Pharma LLC | $80.60 | 2022-2023 | Gralise |
| Otsuka America Pharmaceutical, INC. | $79.65 | 2023-2024 | Nuedexta, Rexulti |
| Xeris Pharmaceuticals, INC. | $70.53 | 2024-2025 | Keveyis |
| Supernus Pharmaceuticals, INC. | $70.48 | 2022-2025 | Qelbree |
| Csl Behring | $67.58 | 2022-2025 | Hizentra |
| Life Molecular Imaging LTD | $63.65 | 2024-2025 | Neuraceq |
| Biohaven Pharmaceuticals, INC. | $57.40 | 2021 | |
| Arbor Pharmaceuticals, INC. | $46.81 | 2021-2022 | |
| Ge Healthcare | $46.71 | 2022-2025 | |
| Allergan, INC. | $46.47 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $45.90 | 2024-2025 | Ormalvi, Tascenso Odt, Bafiertam |
| Neurelis, INC. | $37.07 | 2024 | Valtoco |
| Avion Pharmaceuticals | $35.06 | 2022-2023 | Dhivy |
| Abbott Laboratories | $32.12 | 2022 | |
| Ani Pharmaceuticals, INC. | $25.30 | 2025 | Purified Cortrophin Gel |
| Insightec,INC | $24.85 | 2024 | Exablate |
| Bridgebio Pharma, INC. | $24.76 | 2025 | Attruby |
| Scilex Pharmaceuticals INC. | $24.61 | 2024 | |
| Amicus Therapeutics, INC. | $22.37 | 2025 | |
| Kedrion Biopharma, INC. | $18.62 | 2025 | Kedrab, Koate, Rhogam Ultra-Filtered Plus |
| Banner Life Sciences, LLC | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bondi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.